BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2003
View Archived Issues
Potential cardiovascular benefits induced by rosiglitazone in diabetes and insulin resistance
Read More
Synthetic retinal peptide improves functional activity in diabetic retinopathy
Read More
Improved pharmacokinetic and pharmacodynamic profile found for insulin detemir in type 1 diabetes
Read More
Pioglitazone improves glucose tolerance and microvascular function in type 2 diabetes
Read More
Severe oral mucositis in cancer patients improved by rHuKGF
Read More
Remune enters treatment interruption study in HIV-1-infected patients
Read More
Phase III Theratope vaccine trial fails to meet primary endpoints
Read More
Calpain inhibitors with improved pharmacokinetics and neuroprotective efficacy
Read More
New antibacterial tylosin analogues covered by Enanta patent
Read More
Gabusectin, a novel antibiotic prepared and tested by Aventis researchers
Read More
Adenosine A2A receptor ligands and their use reported by Roche
Read More
Novel CRF antagonists for use in anxiety, depression and IBS
Read More
Sanofi-Synthelabo claims novel TNF-alpha production inhibitors in recent patent
Read More
Lilly reports new series of PPARalpha agonists
Read More
Beta-secretase inhibitors identified by Elan and Pharmacia (Pfizer) team
Read More
Boston Life Sciences to pursue SPA for phase III study of Altropane
Read More
Novuspharma to merge with Cell Therapeutics
Read More
Enzon acquires North American license to ATG-Fresenius S
Read More
Metvix label extension recommended in Australia
Read More
Second phase IIa study for TA-CD in cocaine dependence reports findings
Read More
Enrollment completed in phase II/III European trial of Trabio
Read More
CARDS Lipitor trial stopped two years early because of significant atorvastatin benefit
Read More
Forsteo approved in E.U. for treatment of osteoporosis in postmenopausal women
Read More
FDA approves FluMist as first intranasal influenza vaccine
Read More
Specific human mast cell tryptase inhibitor blocks collagen production in human lung fibroblasts
Read More
New nonestrogenic inhibitors of human steroid sulfatase synthesized at Theramex
Read More